Litcius/Paper detail

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

Thomas L Holland, Adit A. Ginde, Roger Paredes, Thomas A. Murray, Nicole Engen, Greg Grandits, Andrew M. Vekstein, Noel Ivey, Ahmad Mourad, Uriel Sandkovsky, Robert Gottlieb, Mezgebe Berhe, Mamta K. Jain, Rubria Marines‐Price, Barbine Tchamba Agbor Agbor, Lourdes Mateu, Sergio España-Cueto, Gemma Lladós, Eleftherios Mylonakis, Ralph Rogers, Fadi Shehadeh, Michael R. Filbin, Kathryn A. Hibbert, Kami Kim, Thanh Tran, Peter E. Morris, Evan Cassity, Barbara W. Trautner, Lavannya M. Pandit, Kirk U. Knowlton, Lindsay Leither, Michael A. Matthay, Angela J. Rogers, Wonder Drake, Beatrice Jones, Garyphallia Poulakou, Konstantinos N. Syrigos, Eduardo Fernández‐Cruz, Marisa Di Natale, Eyad Almasri, Leire Balerdi-Sarasola, Sanjay Bhagani, Katherine L. Boyle, Jonathan D. Casey, Peter Chen, David J. Douin, D. Clark Files, Huldrych F. Günthard, R. Duncan Hite, Robert C. Hyzy, Akram Khan, Moses Kibirige, Robert Kidega, Ivan Kimuli, Francis Kiweewa, Jens‐Ulrik Stæhr Jensen, Bradley G. Leshnower, Joseph Lutaakome, Prasad Manian, Vidya Menon, José Luís Morales‐Rull, D. Shane O’Mahony, J. Scott Overcash, Srikant Ramachandruni, Jay S. Steingrub, Hassan Taha, Michael R. Waters, Barnaby Edward Young, Andrew Phillips, Daniel D. Murray, Tomas Ø. Jensen, María L. Padilla, David Sahner, Katy Shaw-Saliba, Robin Dewar, Marc Teitelbaum, Ven Natarajan, M. Tauseef Rehman, Sarah Pett, Fleur Hudson, Giota Touloumi, Samuel M. Brown, Wesley H. Self, Christina C. Chang, Adriana Sánchez, Amy Weintrob, Timothy Hatlen, Birgit Grund, Shweta Sharma, Cavan Reilly, Pedro Garbes, Mark T. Esser, Alison Templeton, Abdel G. Babiker, Victoria J. Davey, Annetine C. Gelijns, Elizabeth S. Higgs, Virginia L. Kan, Gail Matthews, Bruce Thompson

2022The Lancet Respiratory Medicine128 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Double blindMEDLINEBetacoronavirusCoronavirus InfectionsPhase (matter)Intensive care medicineInternal medicineAlternative medicineVirologyPlaceboOutbreakPathologyDiseaseOrganic chemistryChemistryPolitical scienceLawInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial | Litcius